Zobrazeno 1 - 10
of 559
pro vyhledávání: '"C, Riche"'
Autor:
C. Riche, J. F. Bouret, N. A. Achour, M. I. Labarre, L. Derenne, A. Ulvoas, D. Martin, Hugues Bourgeois, P. Leynia, T. Matysiak Budnik, G. Piriou, P. L. Etienne, A. M. Vidal, V. Rossi, P. Michel Langlet, D. Déniel Lagadec, Marc Porneuf, M. N. Julien, Olivier Capitain, C. Chouzenoux, E. Jobard, C. Naveau Ploux, Isabelle Cumin, Olivier Dupuis, Loïc Campion, Claire Stampfli, Jean-Yves Douillard, Erick Gamelin, C. Bertrand, A. Brouard, L. Guivarch, V. Guérin Meyer, E. Peguet, Fanny Marhuenda, E. Boucher, Jean-Philippe Metges, L. Miglianico, S. Roussel, A. S. Le Bris Michel, F. Royet, J. Faycal, A. Gourlaouen, P. Thomaré, D. Grasset, F. Riaud, C. Louvigné, Hélène Senellart, S. Barré, S. Rochard, M. Couturier, Oana Cojocarasu, S. Gouva, H. Desclos, J. Egreteau, C. Bertholom, C. Bodin, M. A. Lebot, Jean-Luc Raoul, G. Le Bihan, V. Bicheler, V. Klein, F. Grude, C. Elhannani, R. Largeau, Philippe Deguiral, Roger Faroux, F. Suberville, B. Person, R. Bessard, C. Grollier, E. Crespeau, Jean-François Ramée
Publikováno v:
Oncologie. 16:267-276
En 2006, bevacizumab-FOLFIRI represente la therapie ciblee administrable des la premiere ligne chez les patients porteurs d’un cancer colorectal metastatique non operable. Une serie homogene de 111 patients colliges en region Bretagne et Pays de la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a57a4fa6da77619c25aa6a638626bc01
https://doi.org/10.1007/s10269-014-2391-1
https://doi.org/10.1007/s10269-014-2391-1
Publikováno v:
Oncologie. 11:325-330
De la biologie devenue strategique en clinique aux nouveaux outils d’evaluation diagnostique, des nouvelles therapeutiques ciblees couplees a une chimiotherapie aux effets secondaires controles a la radiotherapie toujours plus precise associee a un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::319c254c4afa3b67ff0056c13c8c853f
https://doi.org/10.1007/s10269-009-1079-4
https://doi.org/10.1007/s10269-009-1079-4
Publikováno v:
Cancer Chemotherapy and Pharmacology. 49:274-280
The effects of paclitaxel, cyclosporine, cyclophosphamide, ifosfamide and tamoxifen on the metabolism of methoxymorpholinodoxorubicin (MMDx), a novel anticancer agent, were investigated using human liver microsomes. Paclitaxel, tamoxifen and cyclospo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346defb9d014db6bf9f8990cb6270ace
https://doi.org/10.1007/s00280-001-0415-1
https://doi.org/10.1007/s00280-001-0415-1
Publikováno v:
Journal of Natural Products. 64:634-637
Three new limonoids, named haperforins C2 (1), F (2), and G (3), were isolated from a sample of Harrisonia perforata leaves collected in Central Vietnam. Their structures were determined by single-crystal X-ray diffraction analyses, and their NMR and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::626a7af13729fae46af8d1e8ec428fe3
https://doi.org/10.1021/np000471z
https://doi.org/10.1021/np000471z
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 356:257-262
Irinotecan (CPT-11) is a new camptothecine derivative presently in development for the treatment of several advanced malignancies. It is converted in vivo to a highly potent metabolite, SN-38, by carboxylesterases. All camptothecine derivatives under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5459cde855932bb76664bc7c14a5628d
https://doi.org/10.1007/pl00005049
https://doi.org/10.1007/pl00005049
Autor:
M. Hamzaoui, O. Provot, F. Grégoire, C. Riche, A. Chiaroni, F. Gay, H. Moskowitz, J. Mayrargue
Publikováno v:
Tetrahedron: Asymmetry. 8:2085-2088
Synthesis of optically active 2-oxo-1-alkylcyclohexane carbonitriles is described leading to access to a new bicyclic simplified analogue of artemisinin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeb3f4ca27a7d4d09375a50e977327a6
https://doi.org/10.1016/s0957-4166(97)00238-3
https://doi.org/10.1016/s0957-4166(97)00238-3
Autor:
F. Lemarchand Venencie, D. Herbreteau, M. C. Riche, M. Borsik, D Reizine, Françoise Gelbert, J. J. Merland, Odile Enjolras
Publikováno v:
Pediatric Surgery International. 11:304-307
Venous malformations are often detected at birth and progressively increase in size if not treated. They can have severe aesthetic and functional consequences. Our purpose is to evaluate therapeutic results with Ethibloc. From 1982 to 1994, we have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2728816a0a3887ade75b42d8c3c9edd
https://doi.org/10.1007/bf00497798
https://doi.org/10.1007/bf00497798
Autor:
J. L. Vignot, C. Riche, Marie-Chantal Leglise, M. A. Le Bot, P. Darodes de Tailly, A.-M. Le Roux
Publikováno v:
Cell Biology and Toxicology. 12:39-53
A cellular model of hematopoiesis which would be more convenient than bone marrow (BM) progenitors and directly relevant to human pathology is needed in order to investigate xenobiotic toxicity. Human umbilical cord blood (HCB), previously shown to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077e10a92a7901bc123fbb72238de5a0
https://doi.org/10.1007/bf00143393
https://doi.org/10.1007/bf00143393
Publikováno v:
Biochemical Pharmacology. 47:2302-2306
Expression of P-glycoprotein, which confers multidrug resistance to a broad range of anticancer drugs, was studied in rat hepatocytes in culture. P-glycoprotein was localized in the plasma membrane by immunohistochemical staining and was evaluated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54254b07e1c45cf5e3532fe546f298e1
https://doi.org/10.1016/0006-2952(94)90270-4
https://doi.org/10.1016/0006-2952(94)90270-4
Publikováno v:
Fundamental & Clinical Pharmacology. 7:345-387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e30e22ec0dbbe0a6673ecbdc757dc121
https://doi.org/10.1111/j.1472-8206.1993.tb00504.x
https://doi.org/10.1111/j.1472-8206.1993.tb00504.x